Pulmonary Embolism News and Research

RSS
A pulmonary embolism is a sudden blockage in a lung artery. The cause is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung.
Three hospitals selected as recipients of the 2009 DVTeamCare Hospital Award

Three hospitals selected as recipients of the 2009 DVTeamCare Hospital Award

IPMT procedure can benefit patients with acute deep vein thrombosis

IPMT procedure can benefit patients with acute deep vein thrombosis

CT can be a preferred technique for diagnosing PE, according to study

CT can be a preferred technique for diagnosing PE, according to study

Initial data from REVLIMID Phase III trial in multiple myeloma patients announced

Initial data from REVLIMID Phase III trial in multiple myeloma patients announced

Data evaluating combination therapy with REVLIMID and rituximab in patients with NHL presented

Data evaluating combination therapy with REVLIMID and rituximab in patients with NHL presented

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Study results comparing REVLIMID regimen to stem cell transplant in multiple myeloma patients

Study results comparing REVLIMID regimen to stem cell transplant in multiple myeloma patients

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin

New oral drug is safe and effective to combat clotting disorder

New oral drug is safe and effective to combat clotting disorder

J&JPRD announces clinical results of new oral anticoagulant therapy for venous thromboembolism

J&JPRD announces clinical results of new oral anticoagulant therapy for venous thromboembolism

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Dabigatran etexilate offers effective therapy to prevent recurrent VTE

Dabigatran etexilate offers effective therapy to prevent recurrent VTE

Biotechnology Consulting Poland applies to the EU for structural and cohesion funding

Biotechnology Consulting Poland applies to the EU for structural and cohesion funding

Risk of having a potentially fatal blood clot after surgery is higher, finds research

Risk of having a potentially fatal blood clot after surgery is higher, finds research

Boehringer Ingelheim to announce positive results from its RE-COVER study

Boehringer Ingelheim to announce positive results from its RE-COVER study

Pulmonary embolism can be diagnosed by combining SPECT and low-dose CT, shows research

Pulmonary embolism can be diagnosed by combining SPECT and low-dose CT, shows research

Hospitals should expand quality control guidelines to improve surgical complications in older patients

Hospitals should expand quality control guidelines to improve surgical complications in older patients

Catheter-directed therapy: First-line treatment option for massive pulmonary embolism

Catheter-directed therapy: First-line treatment option for massive pulmonary embolism

Anemia-reducing medications linked to deep vein thrombosis in cancer patients

Anemia-reducing medications linked to deep vein thrombosis in cancer patients

Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC

Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.